Welcome to the 3rd Annual ISPE-FDA CGMP Conference. The FDA and Industry experts will provide you with the insights you need to ensure quality both day-to-day and strategically, over the product lifecycle. No other event drives critical conversations forward like this annual conference. We are excited you are joining us for these vital discussions. During this content-filled three days, you will have the unique opportunity to interact directly with Industry and FDA representatives.
Dr. Janet Woodcock, Director, CDER, FDA - Bringing Manufacturing, Science and Quality to the Next Level
Mary Oates, PhD, VP, Global Quality Operations, Pfizer - Implementing and Measuring a Culture of Quality
David Smith, Executive Vice President, Global Operations and IS, AstraZeneca - Approaches in Ensuring Reliable Supply from India
With increasing complexity of supply chains and the need to rapidly respond to internal and external demands, we must remain committed to using sound science and risk-based approaches to ensure control. The joint FDA-ISPE program committee has worked hard to assure that you will return to your company equipped with the tools for robust end-to-end controlof your processes in the areas that matter the most: Breakthrough Therapy, Knowledge Management, Tech Transfer, Combo Products, Assessing Blend and Content Uniformity, Process Validation, Data Integrity and Drug Shortages.
Monday , 2 June 2014
08.00 – 09.15
Quality Systems: Lifecycle from Development to Discontinuation (Holiday 1-3 Ballroom)
Welcome and Opening Remarks
Implementing and Measuring a Culture of Quality, Mary Oates, PhD
Bringing Manufacturing, Science and Quality to the Next Level, Janet Woodcock, MD
Each year many people start off with how they are going to be better than the year before and write down unrealistic goals about their professional and personal time next the 365 days.
Our team at Women in Pharma® has sat down and put together a...
Featured in this edition of iSpeak Reading Roundup, are the top blog posts from December 2019. Discover key insights for cleaning validation practices, risk-based approaches to quality, and more for what the pharmaceutical industry was reading last...
Since April 2017, the European Pharmacopeia allows to produce Water for Injection (WFI) using other methods than distillation. Meanwhile, the additional water quality "Highly Purified Water" (HPW) could be found in the Ph. Eur. but will be removed in...